HCII
Hudson Executive Investment Corp. II [HCII] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HCII Stock Summary
In the News
HCII Financial details
Company Rating
Neutral
Market Cap
315M
Income
15.7M
Revenue
0
Book val./share
-1.6
Cash/share
0.05
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
30.55
Forward P/E
-
PEG
-
P/S
-
P/B
-6.32
P/C
0
P/FCF
-39.64
Quick Ratio
0.28
Current Ratio
0.34
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.51
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-57.78%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
6%
ROE
-127%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
25M
Shs Float
22.5M
-
-
-
-
Target Price
-
52W Range
9.7-10.1
52W High
-100%
52W Low
-100%
RSI
0.46
Rel Volume
-
Avg Volume
190.01K
Volume
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 4.94%
Prev Close
-
Price
0
Change
-
HCII Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2021-12-31 |
|---|---|---|
| Revenue per share | 0 | |
| Net income per share | 0.13 | |
| Operating cash flow per share | -0.02 | |
| Free cash flow per share | -0.02 | |
| Cash per share | 0 | |
| Book value per share | 0 | |
| Tangible book value per share | 0.01 | |
| Share holders equity per share | 0 | |
| Interest debt per share | 0 | |
| Market cap | 303.13M | |
| Enterprise value | 303.12M | |
| P/E ratio | 73.81 | |
| Price to sales ratio | 0 | |
| POCF ratio | -398.56 | |
| PFCF ratio | -398.56 | |
| P/B Ratio | -18.99K | |
| PTB ratio | -18.99K | |
| EV to sales | 0 | |
| Enterprise value over EBITDA | -154.17 | |
| EV to operating cash flow | -398.56 | |
| EV to free cash flow | -398.56 | |
| Earnings yield | 0.01 | |
| Free cash flow yield | 0 | |
| Debt to equity | 0 | |
| Debt to assets | 0.07 | |
| Net debt to EBITDA | 0 | |
| Current ratio | 1.01 | |
| Interest coverage | 0 | |
| Income quality | -0.19 | |
| Dividend Yield | 0 | |
| Payout ratio | 0 | |
| Sales general and administrative to revenue | 0 | |
| Research and developement to revenue | 0 | |
| Intangibles to total assets | 0 | |
| Capex to operating cash flow | 0 | |
| Capex to revenue | 0 | |
| Capex to depreciation | 0 | |
| Stock based compensation to revenue | 0 | |
| Graham number | 0.04 | |
| ROIC | -7.86 | |
| Return on tangible assets | 16.37 | |
| Graham Net | 0 | |
| Working capital | 11.88 | |
| Tangible asset value | 0 | |
| Net current asset value | -16.05K | |
| Invested capital | 0 | |
| Average receivables | 0 | |
| Average payables | 0 | |
| Average inventory | 0 | |
| Days sales outstanding | 0 | |
| Days payables outstanding | 0 | |
| Days of inventory on hand | 0 | |
| Receivables turnover | 0 | |
| Payables turnover | 0 | |
| Inventory turnover | 0 | |
| ROE | -257.23 | |
| Capex per share | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0.08 | 1.5 | 0.37 | 0.45 | 0.19 | |
| Operating cash flow per share | 0 | -0.11 | -0.09 | -0.03 | -0.02 | |
| Free cash flow per share | 0 | -0.11 | -0.09 | -0.03 | -0.02 | |
| Cash per share | 0.03 | 0.13 | 0.05 | 0.05 | 0.05 | |
| Book value per share | 7.39 | -2.55 | -2.1 | -1.66 | -1.6 | |
| Tangible book value per share | 7.39 | 37.45 | 37.9 | 38.36 | 38.55 | |
| Share holders equity per share | 7.39 | -2.55 | -2.1 | -1.66 | -1.6 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 304.69M | 61.13M | 61.06M | 61.31M | 61.63M | |
| Enterprise value | 303.76M | 60.3M | 60.78M | 61M | 61.29M | |
| P/E ratio | 31.09 | 1.63 | 6.65 | 5.4 | 12.71 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -9.06K | -86.92 | -111.52 | -285.38 | -498.39 | |
| PFCF ratio | -9.06K | -86.92 | -111.52 | -285.38 | -498.39 | |
| P/B Ratio | 1.32 | -3.83 | -4.66 | -5.92 | -6.18 | |
| PTB ratio | 1.32 | -3.83 | -4.66 | -5.92 | -6.18 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -95.1 | -46.13 | 0 | -233.42 | -295.56 | |
| EV to operating cash flow | -9.03K | -85.74 | -111.01 | -283.9 | -495.71 | |
| EV to free cash flow | -9.03K | -85.74 | -111.01 | -283.9 | -495.71 | |
| Earnings yield | 0.01 | 0.15 | 0.04 | 0.05 | 0.02 | |
| Free cash flow yield | 0 | -0.01 | -0.01 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0.08 | 0.07 | 0.05 | 0.04 | 0.04 | |
| Net debt to EBITDA | 0.29 | 0.63 | 0 | 1.21 | 1.6 | |
| Current ratio | 0.92 | 1.01 | 0.5 | 0.49 | 0.34 | |
| Interest coverage | -116.1 | 0 | 0 | 0 | 0 | |
| Income quality | -0.01 | -0.08 | -0.24 | -0.08 | -0.1 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 3.61 | 9.28 | 4.16 | 4.11 | 2.64 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0.01 | 0.04 | 0.01 | 0.01 | 0 | |
| Graham Net | -0.62 | -2.58 | -2.16 | -1.71 | -1.64 | |
| Working capital | -92.74K | 11.88K | -465.06K | -500.61K | -791.38K | |
| Tangible asset value | 0 | 0 | 0 | 0 | 0 | |
| Net current asset value | -19.23M | -16.05M | -13.3M | -10.56M | -10.2M | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.01 | -0.59 | -0.18 | -0.27 | -0.12 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
HCII Frequently Asked Questions
What is Hudson Executive Investment Corp. II stock symbol ?
Hudson Executive Investment Corp. II is a US stock , located in New york of Ny and trading under the symbol HCII
Is Hudson Executive Investment Corp. II stock public?
Yes, Hudson Executive Investment Corp. II is a publicly traded company.
Company Profile
- Volume Average 190.01K
- Market Capitalization 315M
- CEO Mr. Douglas Lee Braunstein J.D.
- Headquarters New York,NY,US
- IPO Date 2021-03-18
-
Website
https://heic2.com 
Hudson Executive Investment Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was formerly known as Hudson Executive Investment Corp. III and changed its name to Hudson Executive Investment Corp. II in December 2020. Hudson Executive Investment Corp. II was incorporated in 2020 and is based in New York, New York.
